Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significantly longer » significantly lower (Expand Search), significantly larger (Expand Search), significantly higher (Expand Search)
longer decrease » larger decrease (Expand Search), linear decrease (Expand Search), largest decrease (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significantly longer » significantly lower (Expand Search), significantly larger (Expand Search), significantly higher (Expand Search)
longer decrease » larger decrease (Expand Search), linear decrease (Expand Search), largest decrease (Expand Search)
-
461
-
462
-
463
Supplementary Material for: Allopurinol Use is Associated With Decreased Incidence of Hepatic Decompensation and Overall Mortality Among Individuals With Cirrhosis: a Propensity-ma...
Published 2025“…Background: Cirrhosis is associated with significant morbidity and mortality. Recent studies have highlighted the potential role of allopurinol in reducing the incidence of hepatic decompensation among individuals with cirrhosis. …”
-
464
-
465
Table 1_A novel α-conotoxin [D1G, ΔQ14] LvIC decreased mouse locomotor activity.xls
Published 2025“…</p>Conclusion<p>Our findings indicate that α-conotoxin [D1G, ΔQ14] LvIC significantly decreased locomotor activity in mice. Additionally, it altered gene expression primarily in areas related to neuronal development, synapse formation, and neuron activity, while also reducing synapse strength. …”
-
466
Table 2_A novel α-conotoxin [D1G, ΔQ14] LvIC decreased mouse locomotor activity.xls
Published 2025“…</p>Conclusion<p>Our findings indicate that α-conotoxin [D1G, ΔQ14] LvIC significantly decreased locomotor activity in mice. Additionally, it altered gene expression primarily in areas related to neuronal development, synapse formation, and neuron activity, while also reducing synapse strength. …”
-
467
-
468
-
469
-
470
-
471
-
472
Visualization of DNA in an untreated ISP phage stock by immunogold labelling.
Published 2024Subjects: -
473
-
474
Recruitment flow diagram of the current study.
Published 2025“…In phase 2, EQ-5D-5L summary improved most in participants with higher education levels and longer recovery expectations; EQ-VAS improved most in cyclists and patients with longer recovery expectations.…”
-
475
-
476
-
477
-
478
-
479
-
480
(A–D) Representative immunoblots for the reporter assays shown in Fig 4A–D.
Published 2025Subjects: